Interestingly, HNSCC cells highly expressing the complex showed enhanced sensitivity to gefitinib, probably since TMEM16A expression acts positively on EGFR signaling and renders HNSCC cells more sensitive to EGFR inhibition. Here, ANO1 is linked to head and neck squamous cell carcinoma.